IgH gene rearrangement by PCR as an adjunct to flow cytometric analysis for the detection of minimal residual disease in patients with B lymphoblastic leukemia-Reference-Cited by-同舟云学术

IgH gene rearrangement by PCR as an adjunct to flow cytometric analysis for the detection of minimal residual disease in patients with B lymphoblastic leukemia

Published:2020-07-03 Issue:3 Volume:13 Page:137-142
ISSN:1868-9256
Container-title:Journal of Hematopathology
language:en
Short-container-title:J Hematopathol

Author:

Kavesh Mark,Li Ying,Li Peng,Shahid Mohammad,Chaffin Joanna,Seifert Robert^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hematology,Histology,Pathology and Forensic Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12308-020-00406-8.pdf

Reference25 articles.

1. Bader P, Hancock J, Kreyenberg H, Goulden NJ, Niethammer D, Oakhill A, Steward CG, Handgretinger R, Beck JF, Klingebiel T (2002) Minimal residual disease (MRD) status prior to allogeneic stem cell transplantation is a powerful predictor for post-transplant outcome in children with ALL. Leukemia. 16(9):1668–1672

2. Biondi A, Valsecchi MG, Seriu T, D’Aniello E, Willemse MJ, Fasching K, Pannunzio A, Gadner H, Schrappe M, Kamps WA, Bartram CR, van Dongen J, Panzer-Grümayer ER (2000) Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group. Leukemia. 14(11):1939–1943

3. Mussolin L, Pillon M, Conter V, Piglione M, Lo Nigro L, Pierani P, Micalizzi C, Buffardi S, Basso G, Zanesco L, Rosolen A (2007) Prognostic role of minimal residual disease in mature B-cell acute lymphoblastic leukemia of childhood. J Clin Oncol 25(33):5254–5261

4. Borowitz MJ, Wood BL, Devidas M, Loh ML, Raetz EA, Salzer WL, Nachman JB, Carroll AJ, Heerema NA, Gastier-Foster JM, Willman CL, Dai Y, Winick NJ, Hunger SP, Carroll WL, Larsen E (2015) Prognostic significance of minimal residual disease in high risk B-ALL: a report from Children’s Oncology Group study AALL0232. Blood. 126(8):964–971

5. Mannis GN, Martin TG, Damon LE et al (2016) Quantification of acute lymphoblastic leukemia clonotypes in leukapheresed peripheral blood progenitor cells predicts relapse risk after autologous hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 22(6):1030–1036